Dizocilpine Does Not Alter NOS1AP Gene Expression in Rats and in Cell Cultures

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• The NOS1AP gene encodes a protein that regulates nitric oxide (NO) production by interacting with neuronal nitric oxide synthase (nNOS) and NMDA receptors (NMDARs).
• NOS1AP expression increases with NMDAR activation, but its response to NMDAR inhibition is unknown.
• The NOS1AP gene is implicated in schizophrenia, and NMDAR antagonists like dizocilpine are used in animal models of the disorder.

Purpose of the Study:

• To investigate the effect of dizocilpine (MK-801) on NOS1AP gene expression and protein production.
• To examine NOS1AP regulation under conditions of NMDAR inhibition in both in vivo and in vitro models.

Main Methods:

• Rats were injected with a low dose of dizocilpine (0.1 mg/kg).
• SH-SY5Y and HEK293T cell lines were treated with varying concentrations of dizocilpine (10-200 µM).
• Gene expression and protein production of NOS1AP were analyzed in treated samples.

Main Results:

• Dizocilpine treatment did not significantly affect NOS1AP gene expression in rats or cell lines.
• No changes in NOS1AP protein production were observed following dizocilpine administration.
• The study found no impact of NMDAR inhibition on NOS1AP levels.

Conclusions:

• Dizocilpine, a commonly used NMDAR antagonist, does not alter NOS1AP expression or production.
• These findings suggest that NOS1AP regulation is independent of NMDAR activity under the tested conditions.
• This research provides novel insights into the molecular mechanisms potentially relevant to schizophrenia.